Kent D. Stewart

5.2k total citations
91 papers, 3.1k citations indexed

About

Kent D. Stewart is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Kent D. Stewart has authored 91 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 36 papers in Oncology and 30 papers in Organic Chemistry. Recurrent topics in Kent D. Stewart's work include HIV/AIDS drug development and treatment (16 papers), Peptidase Inhibition and Analysis (13 papers) and HIV Research and Treatment (12 papers). Kent D. Stewart is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), Peptidase Inhibition and Analysis (13 papers) and HIV Research and Treatment (12 papers). Kent D. Stewart collaborates with scholars based in United States, United Kingdom and Australia. Kent D. Stewart's co-authors include Dale J. Kempf, Akhteruzzaman Molla, Hing L. Sham, Vincent L. Giranda, Eric F. Johnson, Cele Abad‐Zapatero, Steven W. Muchmore, Thomas J. Sowin, Vincent S. Stoll and Hongmei Mo and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Physiological Reviews.

In The Last Decade

Kent D. Stewart

91 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kent D. Stewart United States 34 1.3k 967 559 518 469 91 3.1k
Tarek S. Mansour United States 43 2.2k 1.8× 2.4k 2.5× 590 1.1× 490 0.9× 436 0.9× 148 5.0k
Bertil Samuelsson Sweden 34 1.6k 1.3× 1.6k 1.7× 843 1.5× 351 0.7× 219 0.5× 134 3.6k
Hing L. Sham United States 37 2.1k 1.6× 2.0k 2.1× 870 1.6× 373 0.7× 558 1.2× 134 4.6k
Malcolm MacCoss United States 36 2.3k 1.9× 3.4k 3.6× 820 1.5× 554 1.1× 405 0.9× 136 6.4k
Pierre Bonneau Canada 24 677 0.5× 394 0.4× 411 0.7× 279 0.5× 199 0.4× 39 1.6k
Maria Zappalà Italy 37 1.5k 1.2× 2.7k 2.8× 699 1.3× 503 1.0× 380 0.8× 185 4.6k
Tanaji T. Talele United States 36 1.8k 1.4× 1.8k 1.8× 589 1.1× 207 0.4× 1.4k 3.1× 98 4.5k
Michael J. Sofia United States 32 1.7k 1.3× 1.1k 1.1× 1.2k 2.1× 1.0k 2.0× 178 0.4× 122 3.8k
John A. Secrist United States 38 3.4k 2.7× 1.7k 1.8× 1.4k 2.6× 780 1.5× 471 1.0× 169 5.5k
William G. Rice United States 39 3.1k 2.4× 972 1.0× 1.2k 2.2× 398 0.8× 791 1.7× 108 5.4k

Countries citing papers authored by Kent D. Stewart

Since Specialization
Citations

This map shows the geographic impact of Kent D. Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent D. Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent D. Stewart more than expected).

Fields of papers citing papers by Kent D. Stewart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kent D. Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent D. Stewart. The network helps show where Kent D. Stewart may publish in the future.

Co-authorship network of co-authors of Kent D. Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of Kent D. Stewart. A scholar is included among the top collaborators of Kent D. Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent D. Stewart. Kent D. Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macpherson, Iain R., Srinivasu Poondru, George R. Simon, et al.. (2012). A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours. European Journal of Cancer. 49(4). 782–789. 10 indexed citations
2.
Ji, Zhiqin, Yujia Dai, Cele Abad‐Zapatero, et al.. (2012). Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(14). 4528–4531. 5 indexed citations
3.
Vasudevan, Anil, Clara I. Villamil, Kent D. Stewart, et al.. (2012). Contribution of indazolinone tautomers to kinase activity. Bioorganic & Medicinal Chemistry Letters. 22(14). 4502–4505. 2 indexed citations
4.
Randolph, John T., Charles A. Flentge, Peggy Huang, et al.. (2009). Synthesis and Biological Characterization of B-Ring Amino Analogues of Potent Benzothiadiazine Hepatitis C Virus Polymerase Inhibitors. Journal of Medicinal Chemistry. 52(10). 3174–3183. 34 indexed citations
5.
Dai, Yujia, Niru B. Soni, Lori J. Pease, et al.. (2007). Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 386–390. 31 indexed citations
6.
Tong, Yunsong, Zhi‐Fu Tao, Jennifer J. Bouska, et al.. (2007). Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: Improving oral biovailability. Bioorganic & Medicinal Chemistry Letters. 17(20). 5665–5670. 5 indexed citations
7.
Lu, Liangjun, Sherie Masse, Ron Pithawalla, et al.. (2007). Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro. Antiviral Research. 76(1). 93–97. 29 indexed citations
8.
Dinges, Jürgen, Irini Akritopoulou‐Zanze, Lee D. Arnold, et al.. (2006). Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(16). 4371–4375. 19 indexed citations
9.
Heyman, H. Robin, Robin R. Frey, Peter F. Bousquet, et al.. (2006). Thienopyridine urea inhibitors of KDR kinase. Bioorganic & Medicinal Chemistry Letters. 17(5). 1246–1249. 33 indexed citations
10.
Stewart, Kent D., et al.. (2006). Drug Guru: A computer software program for drug design using medicinal chemistry rules. Bioorganic & Medicinal Chemistry. 14(20). 7011–7022. 71 indexed citations
11.
Dowell, Barry L., Kent D. Stewart, Vibeke Jensen, et al.. (2005). Establishment and Characterization of 7 New Monoclonal Antibodies to Tissue Inhibitor of Metalloproteinases-1. Tumor Biology. 26(2). 71–80. 23 indexed citations
12.
Stoner, Eric J., M.S. Allen, Rodger F. Henry, et al.. (2005). An Unusual Intramolecular Hetero-Diels−Alder Cycloaddition. The Journal of Organic Chemistry. 70(8). 3332–3335. 1 indexed citations
13.
Mo, Hongmei, Alex K. Konstantinidis, Kent D. Stewart, et al.. (2004). Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction. Virology. 329(2). 319–327. 38 indexed citations
14.
Stewart, Kent D., et al.. (2004). An intramolecular ionic hydrogen bond stabilizes a cis amide bond rotamer of a ring‐opened rapamycin‐degradation product. Magnetic Resonance in Chemistry. 43(1). 41–46. 11 indexed citations
15.
Stewart, Kent D. & Celerino Abad‐Zapatero. (2001). Candida Proteases and Their Inhibition Prospects for Antifungal Therapy. Current Medicinal Chemistry. 8(8). 941–948. 43 indexed citations
16.
Abad‐Zapatero, Cele, Robert C. Goldman, Steven W. Muchmore, et al.. (1998). Structure of Secreted Aspartic Proteinases from Candida. Advances in experimental medicine and biology. 436. 297–313. 13 indexed citations
17.
Dennis, Barbara H., Paul W. Stewart, Catherine M. Champagne, et al.. (1998). Diet Design for a Multicenter Controlled Feeding Trial. Journal of the American Dietetic Association. 98(7). 766–766. 29 indexed citations
18.
Stewart, Kent D., et al.. (1998). Discovery of a new cyclooxygenase-2 lead compound through 3-D database searching and combinatorial chemistry. Bioorganic & Medicinal Chemistry Letters. 8(5). 529–534. 25 indexed citations
19.
Kempf, Dale J., Akhteruzzaman Molla, Kennan C. Marsh, et al.. (1997). Lack of stereospecificity in the binding of the P2 amino acid of ritonavir to HIV protease. Bioorganic & Medicinal Chemistry Letters. 7(6). 699–704. 4 indexed citations
20.
Strękowski, Lucjan, Donald B. Harden, Roman L. Wydra, Kent D. Stewart, & W. David Wilson. (1989). Molecular basis for potentiation of bleomycin‐mediated degradation of DNA by polyamines. Experimental and molecular mechanical studies. Journal of Molecular Recognition. 2(4). 158–166. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tarek S. Mansour Breakdown of academic impact, for papers by Bertil Samuelsson Breakdown of academic impact, for papers by Hing L. Sham Breakdown of academic impact, for papers by Malcolm MacCoss Breakdown of academic impact, for papers by Pierre Bonneau Breakdown of academic impact, for papers by Maria Zappalà Breakdown of academic impact, for papers by Tanaji T. Talele Breakdown of academic impact, for papers by Michael J. Sofia Breakdown of academic impact, for papers by John A. Secrist Breakdown of academic impact, for papers by William G. Rice
Rankless by CCL
2026